superguru
MenuClose menu

Retail fund brand

Cruelty Free Super

Cruelty Free Super gives animal-welfare concerns a central role in its ethical approach. It replaced its single Growth option with three choices in 2024.

THE OVERVIEW

About Cruelty Free Super

The product operates within Professional Super, a sub-fund of OneSuper, with Diversa as trustee.

Sources123

Who can join

Public membership is available under the current product documents.

Visit the official website

THE SUPERGURU VIEW

Our take

Editorial assessment

A candidate for people whose animal-welfare requirements are not met by a mainstream fund's screening policy.

What deserves a closer look

  • Ethical screens apply to the share options, not the Cash option. A shares-only allocation has different risk from a diversified balanced fund.
  • Confirm insurance-transfer acceptance before closing existing cover.

Sources123

Based on the cited product features. These are general reasons to investigate the fund, not a personal recommendation. Supporting sources.

THE NUMBERS

Fees and investment returns

Use the product, investment option and employer plan on your statement. Lifecycle members need to choose the relevant stage. APRA's investment pathways may include closed options held by existing members.

No investment pathway has been matched to this profile in the June 2026 APRA package. Read the fee and performance notes below and use the fund's current documents. Absence from this dataset is not a performance-test failure.

Source: APRA Comprehensive Product Performance Package 2026, published 28 August 2026. Fees reflect the reporting year to 30 June 2026, are net of tax, use standard arrangements and exclude member-activity fees. Dollar figures are rounded. They are not a current quote. Check the latest PDS for changes, insurance premiums and any separately charged advice.

Returns are annualised historical results. Different return bases, risk levels and periods cannot be treated as interchangeable. MySuper net returns use a $50,000 representative balance even when you change the fee balance. A lifecycle stage return does not track a person moving between stages. Missing figures mean not reported, not zero. Past returns do not predict future returns. Read our method and APRA's definitions.

A CLOSER LOOK

Inside Cruelty Free Super

Accounts and products

Cruelty Free Super accumulation.

Sources123

Investment choices

The current choices are Cruelty Free Australian Shares, Cruelty Free International Shares and Cash. Members select their own mix; these are not three diversified balanced portfolios.

Sources123

Insurance

AIA provides insurance. The FAQ says a transfer of existing insurance generally needs to be completed within 30 days of leaving the other fund.

Sources123

Retirement income

The reviewed FAQ explains retirement withdrawals but does not establish a dedicated pension product. Check the income-stream pathway before retirement.

Sources123

Advice and support

Member services provide product support; personal advice needs a qualified adviser.

Sources123

Fee details to check

Use the current PDS and reference guide for the chosen option, including administration, investment and insurance costs.

Sources123

Comparing investment performance

Read option inception and change dates; the pre-2024 single-option record is not the same record as every current option.

Sources123

Features worth considering

An ethical approach centred on animal welfare.

Separate Australian-share, international-share and cash choices.

Sources123

THE LEGAL FUND

Fund size in APRA's annual reporting

OneSuper

Total assets$7,627,323,000
Member accounts261,958

At 30 June 2025. These are legal-fund totals, which can include several products and more than one account per person.

APRA annual fund-level statistics, June 2025. These older totals can differ substantially after mergers. Size is not a measure of suitability or investment quality.

Sources for Cruelty Free Super

Checked 2026-09-11. Documents and product terms can change after this date.

  1. Current product and trustee
  2. FAQs and insurance
  3. Current investment choices and screening scope